Healthy donors needed for research – no treatment involved
NCT ID NCT00339911
First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 14 times
Summary
This study creates a bank of blood, cheek cells, semen, urine, or nail clippings from up to 1,200 healthy adult volunteers. The samples are used by scientists for lab research only, such as studying immune function or developing tests. Donors are paid for their time and must be NCI-Frederick employees.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 1999
- Expected to finish
-
Oct 2030
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Healthy NCI Frederick Cancer Research and Development Center employees@@@@@@
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: Individuals must meet the following eligibility criteria to be entered into the RDP donor pool, as follows: 1. Age 18 or older. 2. Weight of 110 lb or greater. 3. All subjects must have the ability and agree to participate fully and comply with the procedures of the protocol and provide informed consent. 4. Registration for participation in semen donation is limited to males currently enrolled in the donor pool. 5. Subjects must be NCI Frederick Employees EXCLUSION CRITERIA: Individuals with any of the following will be excluded from the donor pool: 1. History of chronic illness that might increase the risks associated with phlebotomy, including but not limited to heart, lung, or kidney disease 2. Current acute illness. 3. History of clotting disorders. 4. Current medications which might increase the risks associated with phlebotomy. 5. History of syncope or other difficulty with venipuncture. 6. Anemia, as determined by hematocrit or hemoglobin. Hematocrit Acceptable range for males: 40-51 percent. Hematocrit Acceptable range for females: 34-46 percent. 7. Hemoglobin Acceptable range for males: 12.5-17.0 g/dl Hemoglobin Acceptable range for females: 11.5-15.2 g/dl 8. Positive blood test for exposure to HIV-1, HIV-2, HTLV-1, HTLV-2, or HCV or for HBV surface antigens. 9. Individuals whose activities or conditions place them at high risk of HIV infection are asked not to donate. 10. Males who qualify for participation in the donor pool will be excluded from participation in semen donation if they have knowingly had any injury, infection, or treatment performed that renders them incapable of producing sperm. 11. Pregnancy: Pregnant women will not be allowed to enroll in this study because there is no benefit.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy donors are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
NCI Frederick Cancer Research Center
Frederick, Maryland, 21702-1201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.